Table: begin end state 1 40 cytoplasmic 41 60 transmembrane 61 65 non-cytoplasmic 66 88 transmembrane 89 99 cytoplasmic 100 120 transmembrane 121 125 non-cytoplasmic 126 148 transmembrane 149 164 cytoplasmic 165 189 transmembrane 190 200 non-cytoplasmic 201 220 transmembrane 221 257 cytoplasmic 258 279 transmembrane 280 294 non-cytoplasmic 295 312 transmembrane 313 323 cytoplasmic 324 342 transmembrane 343 347 non-cytoplasmic 348 372 transmembrane 373 384 cytoplasmic 385 409 transmembrane 410 416 non-cytoplasmic 417 436 transmembrane 437 447 cytoplasmic
Input: >WP_090448576.1 NCBI__GCF_900100495.1:WP_090448576.1 MSASSESLAYGRAPSRSTSSERSTLRRAATASFIGNFVEWFDYAAYGYLAAVIAVVFFPA TDKTSGLLAAFAVFAISFIVRPIGGIVWGHIGDRYGRRNALSLSILIMSGATFCIAFLPT YAQVGLWAPLLLLLIRLVQGFSASGEYAGASAFLAEYAPDNRRGFFTSLVPASTAAGLLF GSLFAAMLYSQLDGEQLHSWGWRLPFLLAAPMGLIGRYIRLHLQDTPKFREMEQALEKKE GEHKVPIRELFGAQRKRVLVAIGVTCLNAVAFYLILSYMPTYLATEMGMNETDSFLASTV SLATYIGFIFLMGKLSDRFGRKTMLILASLLFLGLTLPLFGMLEGRSFAFILLIQIAFGL MLAMNDGTLPCFLAEIFPTRVRYSGFAFSFNTANALFGGTAPFIATWLISQSGDKMAPAW MLMGAAAVALVAMLMITETAHKALADD
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server